Cheng‐Hui Lu
Impact in
-
- MicroRNA in disease regulation
Papers in
-
- Thyroid Cancer Diagnosis and Treatment 10
-
- Atrial Fibrillation Management and Outcomes 2
- Cardiovascular Issues in Pregnancy 2
- Co-authors
- Xinfeng Liu (11 shared papers)Xufu Wang (14 shared papers)Zenghua Wang (8 shared papers)Guoqiang Wang (8 shared papers)Guo‐Ming Wang (3 shared papers)Qin Zhang (2 shared papers)Qingbo Yang (2 shared papers)Jiao Li (6 shared papers)
- Journals
- Medicine (4 papers)Frontiers in Endocrinology (3 papers)Construction and Building Materials (2 papers)Scientific Reports (2 papers)PLoS ONE (2 papers)
- Partner nations
- ChinaTaiwanUnited States
In The Last Decade
Cheng‐Hui Lu
40 papers receiving 491 citations
Peers
Comparison fields: 5 of 73
- Drug Discovery 1
- Cancer Research 46
- Cardiology and Cardiovascular Medicine 77
- Ocean Engineering 43
- Oncology 66
Countries citing papers authored by Cheng‐Hui Lu
This map shows the geographic impact of Cheng‐Hui Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cheng‐Hui Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cheng‐Hui Lu more than expected).
Fields of papers citing papers by Cheng‐Hui Lu
This network shows the impact of papers produced by Cheng‐Hui Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cheng‐Hui Lu. The network helps show where Cheng‐Hui Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Cheng‐Hui Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 113 | |
| 2 | 2023 | 52 | |
| 3 | MiR-21 suppresses endothelial progenitor cell proliferation by activating the TGFβ signaling pathway via downregulation of WWP1. | 2015 | 33 |
| 4 | 2015 | 33 | |
| 5 | 2019 | 28 | |
| 6 | 2017 | 22 | |
| 7 | 2020 | 20 | |
| 8 | 2023 | 19 | |
| 9 | 2019 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2024 | 16 | |
| 12 | 2025 | 15 | |
| 13 | 2017 | 13 | |
| 14 | 2020 | 11 | |
| 15 | 2019 | 9 | |
| 16 | 2020 | 9 | |
| 17 | 2021 | 9 | |
| 18 | 2022 | 9 | |
| 19 | 2020 | 8 | |
| 20 | 2020 | 7 |
About Cheng‐Hui Lu
Cheng‐Hui Lu is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine, Periodontics, Cancer Research and Pulmonary and Respiratory Medicine, having authored 45 papers that have together received 508 indexed citations. Recurring topics across this work include Thyroid Cancer Diagnosis and Treatment (10 papers), Aortic Disease and Treatment Approaches (3 papers), Atrial Fibrillation Management and Outcomes (2 papers), T-cell and B-cell Immunology (2 papers), Oral Health Pathology and Treatment (2 papers), Laser Applications in Dentistry and Medicine (2 papers), Cardiovascular Issues in Pregnancy (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Drug Discovery (1 citation), Cancer Research (46 citations), Cardiology and Cardiovascular Medicine (77 citations), Ocean Engineering (43 citations) and Oncology (66 citations). Cheng‐Hui Lu has collaborated with scholars based in China, Taiwan and United States. Frequent co-authors include Xinfeng Liu, Xufu Wang, Zenghua Wang, Guoqiang Wang, Guo‐Ming Wang, Qin Zhang, Qingbo Yang, Jiao Li, Na Han and Bin Liu. Their work appears in journals such as Medicine, Frontiers in Endocrinology, Construction and Building Materials, Scientific Reports and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.